首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝型脂肪酸结合蛋白在糖尿病中的研究
引用本文:王 静,郭宏敏.肝型脂肪酸结合蛋白在糖尿病中的研究[J].医学信息,2019,0(18):18-20.
作者姓名:王 静  郭宏敏
作者单位:1.太仓中医医院内分泌科,江苏 太仓 215400; 2.江苏省中医院老年科,江苏 南京 210029
摘    要:肝型脂肪酸结合蛋白(L-FABP)在肝脏、肾脏等组织细胞中表达。有研究表明,L-FABP与糖尿病的发生、发展密切相关。同时作为肾损伤的敏感指标,尿L-FABP成为糖尿病肾病早期诊断的标志物之一并能预测病情的转归。本文就肝型脂肪酸结合蛋白在糖尿病中的研究进展进行综述。

关 键 词:肝型脂肪酸结合蛋白  糖尿病  糖尿病肾病

Study on Hepatic Fatty Acid Binding Protein in Diabetes
WANG Jing,GUO Hong-min.Study on Hepatic Fatty Acid Binding Protein in Diabetes[J].Medical Information,2019,0(18):18-20.
Authors:WANG Jing  GUO Hong-min
Institution:1.Department of Endocrinology,Taicang Hospital of Traditional Chinese Medicine,Taicang 215400,Jiangsu,China; 2.Department of Geriatrics,Jiangsu Provincial Hospital of Traditional Chinese Medicine,Nanjing 210029,Jiangsu,China
Abstract:Abstract:Hepatic fatty acid binding protein (L-FABP) is expressed in tissue cells such as liver and kidney. Studies have shown that L-FABP is closely related to the occurrence and development of diabetes. At the same time, as a sensitive indicator of kidney injury, urinary L-FABP becomes one of the early markers of diabetic nephropathy and can predict the outcome of the disease. This article reviews the research progress of hepatic fatty acid binding protein in diabetes.
Keywords:Key words:Hepatic fatty acid binding protein  Diabetes  Diabetic nephropathy
点击此处可从《医学信息》浏览原始摘要信息
点击此处可从《医学信息》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号